Cardiometabolic Risk

James Matera, DO, on Appropriate BP Targets in Kidney Disease

07/19/2020

 

James Matera, DO, from CentraState Medical Center in Freehold, New Jersey, discusses optimal blood pressure targets in patients with kidney disease, and how the 2017 hypertension guidelines issued by the American Heart Association and American College of Cardiology affect these targets.

James Matera DO, FACOI, is the Medical Director of Population Health at CentraState Medical Center in Freehold, New Jersey.

For more content relating to nephrology, visit our Medical Resource Center.

Related Content

Lipids
Lipids
Peter Jones, MD, on Managing Abnormal Lipid Levels
06/11/2018
Dr Peter Jones from Houston Methodist Hospital discusses cardiovascular disease and lipids, topics in which he is speaking about during Consultant360's Cardiometabolic Risk Summit this year.
06/11/2018
podcast
podcast
Clinicians’ Concerns for the Future of CABP
10/06/2022
In this podcast, Christian Sandrock, MD, MPH, talks about how the current burden of community-acquired bacterial pneumonia (CABP) has impacted clinicians' concerns about the future, the increasing burden of...
10/06/2022
Pulmonology
Pulmonology
Ashish Khanna, MD, on the PRODIGY Trial and Risk Score
05/25/2019
Dr Khanna, from Cleveland Clinic, discusses his research on a novel opioid-induced respiratory depression risk score.
05/25/2019
Pneumonia
Pneumonia
Arnold Markowitz, MD, on His Suggestion to Revisit CAP Treatment Guidelines
05/21/2020
After analyzing data from his own community teaching hospital, Arnold Markowitz, MD, suggests that the recently updated guideline for the treatment of community-acquired pneumonia be revisited from a local...
05/21/2020
Cardiometabolic Risk
Cardiometabolic Risk
Michael Bloch, MD, on the New "Prehypertension"
06/27/2018
<p>Dr Michael Bloch from Blue Spruce Medical Consultants talks about the ACP's new hypertension guidance, the new "prehypertension" group of patients, and more.</p>
06/27/2018